An anonymous director reports

VECTOR SCIENCE AND THERAPEUTICS CORP. ISSUES OPTIONS

Vector Science and Therapeutics Corp.'s board of directors has approved the grant of 150,000 stock options to an officer of the company in accordance with the company's stock option plan. The options vest in 25-per-cent tranches over a three-year period, have an exercise price of $1.80 and are exercisable for a period of five years from the date of grant. This grant of the options is subject to the approval of the TSX Venture Exchange.

As of the date hereof, a total of 7,336,610 common shares of the company are reserved for issuance under the company's stock option plan, with 8,388,183 options remaining for issuance thereunder.

About Vector Science and Therapeutics Corp.

Vector Science, headquartered in Mequon, Wis., develops novel biomechanical devices and active localized drug delivery platforms to equip clinicians with site-directed interventions where precision matters and systemic risks are unacceptable. The company's shares are listed on the TSX Venture Exchange under the symbol PAIN.